Changes for page Neurodiagnoses
Last modified by manuelmenendez on 2025/03/03 22:46
From version 14.1
edited by manuelmenendez
on 2025/01/27 23:58
on 2025/01/27 23:58
Change comment:
There is no comment for this version
To version 5.1
edited by manuelmenendez
on 2025/01/27 23:04
on 2025/01/27 23:04
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
-
Attachments (0 modified, 0 added, 1 removed)
-
Objects (1 modified, 0 added, 2 removed)
Details
- Page properties
-
- Content
-
... ... @@ -2,10 +2,9 @@ 2 2 ((( 3 3 (% class="container" %) 4 4 ((( 5 -= //A new tridimensionaldiagnostic framework for CNS conditions//=5 += Neurodiagnoses = 6 6 7 -This project is focused on developing a novel nosological and diagnostic framework for neurological diseases by using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies. 8 -We aim to create a structured, interpretable, and scalable diagnostic tool. 7 +This project is focused on developing a novel nosological and diagnostic framework for neurological diseases. Using advanced AI techniques and integrating data from neuroimaging, biomarkers, and biomedical ontologies, we aim to create a structured, interpretable, and scalable diagnostic tool. 9 9 ))) 10 10 ))) 11 11 ... ... @@ -13,66 +13,19 @@ 13 13 ((( 14 14 (% class="col-xs-12 col-sm-8" %) 15 15 ((( 16 -= What is this about and whatcan I find here? =15 += What can I find here? = 17 17 18 -== **Overview** == 19 - 20 -The //Tridimensional Diagnostic Framework// redefines how neurodegenerative diseases (NDDs) are classified by focusing on: 21 - 22 -* **Axis 1**: Etiology (genetic/sporadic and environmental factors). 23 -* **Axis 2**: Molecular Markers (biomarkers and proteinopathies). 24 -* **Axis 3**: Neuroanatomoclinical correlations (linking clinical symptoms to structural changes in the nervous system). 25 - 26 -[[Neurodegenerative diseases can be studied and classified in a tridimensional scheme with three axes: anatomic–clinical, molecular, and etiologic. CSF, cerebrospinal fluid; FDG, fluorodeoxyglucose; MRI, magnetic resonance imaging; PET, positron emission tomography.>>image:tridimensional.png||alt="tridimensional view of neurodegenerative diseases"]] 27 - 28 -This methodology enables: 29 - 30 -* Greater precision in diagnosis. 31 -* Integration of incomplete datasets using AI-driven probabilistic modeling. 32 -* Stratification of patients for personalized treatment. 33 - 34 -== **Diagnostic Axes** == 35 - 36 -* ((( 37 -**Axis 1: Etiology** 38 - 39 -* //Description//: Focuses on genetic and sporadic causes, identifying risk factors and potential triggers. 40 -* //Examples//: APOE ε4 as a genetic risk factor, or cardiovascular health affecting NDD progression. 41 -* //Tests//: Genetic testing, lifestyle and cardiovascular screening. 42 -))) 43 -* ((( 44 -**Axis 2: Molecular Markers** 45 - 46 -* //Description//: Analyzes primary (amyloid-beta, tau) and secondary biomarkers (NFL, GFAP) for tracking disease progression. 47 -* //Examples//: CSF amyloid-beta concentrations to confirm Alzheimer’s pathology. 48 -* //Tests//: Blood/CSF biomarkers, PET imaging (Tau-PET, Amyloid-PET). 49 -))) 50 -* ((( 51 -**Axis 3: Neuroanatomoclinical** 52 - 53 -* //Description//: Links clinical symptoms to neuroanatomical changes, such as atrophy or functional impairments. 54 -* //Examples//: Hippocampal atrophy correlating with memory deficits. 55 -* //Tests//: MRI volumetrics, FDG-PET, neuropsychological evaluations. 56 -))) 57 - 58 -== **Applications** == 59 - 60 -This system enhances: 61 - 62 -* **Research**: By stratifying patients, reduces cohort heterogeneity in clinical trials. 63 -* **Clinical Practice**: Provides dynamic diagnostic annotations with timestamps for longitudinal tracking. 64 - 65 65 == Who has access? == 66 66 67 67 We welcome contributions from the global community. Let’s build the future of neurological diagnostics together! 68 68 69 -== How to Contribute == 21 +== How to Contribute: == 70 70 71 71 * Access the `/docs` folder for guidelines. 72 72 * Use `/code` for the latest AI pipelines. 73 73 * Share feedback and ideas in the wiki discussion pages. 74 74 75 -== Key Objectives == 27 +== Key Objectives: == 76 76 77 77 * Develop interpretable AI models for diagnosis and progression tracking. 78 78 * Integrate data from Human Phenotype Ontology (HPO), Gene Ontology (GO), and other biomedical resources. ... ... @@ -86,7 +86,7 @@ 86 86 {{toc/}} 87 87 {{/box}} 88 88 89 -== Main contents == 41 +== Main contents: == 90 90 91 91 * `/docs`: Documentation and contribution guidelines. 92 92 * `/code`: Machine learning pipelines and scripts.
- tridimensional.png
-
- Author
-
... ... @@ -1,1 +1,0 @@ 1 -XWiki.manuelmenendez - Size
-
... ... @@ -1,1 +1,0 @@ 1 -149.8 KB - Content
- Collaboratory.Apps.Collab.Code.CollabClass[0]
-
- Public
-
... ... @@ -1,1 +1,1 @@ 1 - Yes1 +No
- XWiki.XWikiRights[3]
-
- Allow/Deny
-
... ... @@ -1,1 +1,0 @@ 1 -Allow - Levels
-
... ... @@ -1,1 +1,0 @@ 1 -view - Users
-
... ... @@ -1,1 +1,0 @@ 1 -XWiki.XWikiGuest
- XWiki.XWikiRights[4]
-
- Allow/Deny
-
... ... @@ -1,1 +1,0 @@ 1 -Allow - Groups
-
... ... @@ -1,1 +1,0 @@ 1 -XWiki.XWikiAllGroup - Levels
-
... ... @@ -1,1 +1,0 @@ 1 -view